Amicus Therapeutics

Amicus Therapeutics is a global biotechnology company headquartered in Philadelphia, Pennsylvania. With a workforce of 432 employees, the company generated $500 million in revenue. Amicus Therapeutics is dedicated to developing and delivering high-quality medicines for individuals living with rare metabolic diseases. The company focuses on discovering, developing, and delivering innovative therapies for patients with these challenging conditions. Their patient-centric approach emphasizes incorporating the patient perspective throughout the entire drug development process. Amicus Therapeutics strives to make a meaningful difference in the lives of those affected by rare diseases. Driven by a culture of empathy, compassion, and tenacity, Amicus Therapeutics is committed to advancing cutting-edge technologies. Their core values of mission-dedication, innovation, performance, and integrity guide their efforts to develop and deliver life-changing therapies. For more information about Amicus Therapeutics and their career opportunities, visit www.amicusrx.com.